Page last updated: 2024-08-26

bismuth and Leukemia, Lymphocytic, Chronic, B-Cell

bismuth has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Apostolidis, C; Bacher, K; de Gelder, V; De Vos, F; Dierckx, RA; Lahorte, C; Molinet, R; Nikula, TK; Offner, F; Philippé, J; Slegers, G; Thierens, H; Vandenbulcke, K; Vral, A	1
Apostolidis, C; Bacher, K; de Gelder, V; De Vos, F; Dierckx, RA; Janssens, A; Morgenstern, A; Offner, F; Philippé, J; Slegers, G; Thierens, H; Vandenbulcke, K	1
Campbell, DR; Cherian, R; McGregor, DH; Weston, AP	1

Reviews

1 review(s) available for bismuth and Leukemia, Lymphocytic, Chronic, B-Cell

Article	Year
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics. Digestive diseases and sciences, 1994, Volume: 39, Issue:12 Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Ranitidine; Salicylates; Stomach; Stomach Neoplasms	1994

Article

Year

Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.

Digestive diseases and sciences, 1994, Volume: 39, Issue:12

Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Ranitidine; Salicylates; Stomach; Stomach Neoplasms

1994

Other Studies

2 other study(ies) available for bismuth and Leukemia, Lymphocytic, Chronic, B-Cell

Article	Year
In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:10 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Apoptosis; Bismuth; Chromosome Aberrations; Chromosomes; Dose-Response Relationship, Radiation; Female; Gamma Rays; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Models, Biological; Radiation Dosage; Radioisotopes; Reference Values; Relative Biological Effectiveness; Rituximab; Treatment Outcome	2003
In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia. Cancer biotherapy & radiopharmaceuticals, 2006, Volume: 21, Issue:4 Topics: Alpha Particles; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bismuth; Combined Modality Therapy; Drug Synergism; Gamma Rays; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Energy Transfer; Radioisotopes	2006

Article

Year

In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.

European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:10

Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Apoptosis; Bismuth; Chromosome Aberrations; Chromosomes; Dose-Response Relationship, Radiation; Female; Gamma Rays; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Models, Biological; Radiation Dosage; Radioisotopes; Reference Values; Relative Biological Effectiveness; Rituximab; Treatment Outcome

2003

In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia.

Cancer biotherapy & radiopharmaceuticals, 2006, Volume: 21, Issue:4

Topics: Alpha Particles; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bismuth; Combined Modality Therapy; Drug Synergism; Gamma Rays; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Energy Transfer; Radioisotopes

2006